Table 4.
Comparisons of minor allelic and genotypic frequencies of single nucleotide polymorphisms (SNPs) between female and male Parkinson's disease (PD) patients and the controls.
| Minor allele of each SNP | PD (N, %) | Controls (N, %) | OR (95% CI) | P value |
|---|---|---|---|---|
| Female (allele) | 556 | 636 | ||
| ACMSD-TMEM163 rs6430538, C | 9 (1.6) | 8 (1.3) | 1.29 (0.49∼3.37) | 0.60 |
| TT | 270 (97.1) | 310 (97.5) | ||
| TC | 7 (2.5) | 8 (2.5) | 1.01 (0.36∼2.81) | 0.99 |
| CC | 1 (0.4) | 0 | ||
| MCCC1 rs12637471, G | 251 (45.1) | 277 (43.6) | 1.07 (0.85∼1.34) | 0.58 |
| AA | 83 (29.9) | 99 (31.1) | ||
| GA | 139 (50.0) | 161 (50.6) | 1.03 (0.71∼1.49) | 0.88 |
| GG | 56 (20.1) | 58 (18.2) | 1.15 (0.72∼1.84) | 0.56 |
| BCKDK-STX1B rs14235, G | 60 (10.8) | 61 (9.6) | 1.14 (0.78∼1.66) | 0.49 |
| AA | 219 (78.8) | 260 (81.8) | ||
| GA | 58 (20.9) | 55 (17.3) | 1.25 (0.83∼1.89) | 0.28 |
| GG | 1 (0.4) | 3 (0.9) | 0.40 (0.04∼3.83) | 0.41 |
|
| ||||
| Male (allele) | 642 | 560 | ||
| ACMSD-TMEM163 rs6430538, C | 7 (1.1) | 12 (2.1) | 0.50 (0.20∼1.29) | 0.14 |
| TT | 314 (97.8) | 268 (95.7) | ||
| TC | 7 ((2.2) | 12 (4.3) | 0.50 (0.19∼1.28) | 0.14 |
| CC | 0 | 0 | ||
| MCCC1 rs12637471, G | 260 (40.5) | 240 (42.9) | 0.91 (0.72∼1.14) | 0.41 |
| AA | 114 (35.5) | 93 (33.2) | ||
| GA | 154 (48.0) | 134 (47.9) | 0.94 (0.66∼1.34) | 0.72 |
| GG | 53 (16.5) | 53 (18.9) | 0.82 (0.51∼1.30) | 0.39 |
| BCKDK-STX1B rs14235, G | 59 (9.2) | 54 (9.6) | 0.95 (0.64∼1.40) | 0.79 |
| AA | 264 (82.2) | 228 (81.4) | ||
| GA | 55 (17.1) | 50 (17.9) | 0.95 (0.62∼1.45) | 0.81 |
| GG | 2 (0.6) | 2 (0.7) | 0.86 (0.12∼6.18) | 0.88 |
SNP: single nucleotide polymorphism; OR: odds ratio; CI: confidence interval.